BCPC Balchem Corporation
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.…
Industry Peers
Specialty ChemicalsKey Statistics
About Balchem (NASDAQ: BCPC)
›
Balchem (NASDAQ: BCPC) is listed on Nasdaq, where its shares trade in USD. It belongs to the Specialty Chemicals industry, part of the Basic Materials sector, and reports about 1,430 employees.
The shares were at 165.54 USD on 19 November 2026, up 9.6% over 52 weeks. Its 52-week range is 147.18 USD to 186.15 USD: the price is 11.1% below the high and 12.5% above the low.
At a market capitalisation of 5.26B USD, it trades at 31.2 times trailing earnings and 26.0 times forward earnings. The median trailing P/E of its 18 largest Specialty Chemicals peers is 34.0, so BCPC is valued in line with them. It pays a dividend yielding 0.57% (it pays out 18% of its earnings), against a median of 1.76% among the dividend payers in that peer group.
Balchem reports return on equity of 12.3%, an operating margin of 20.7% and revenue up 8.6% year over year.
Its debt exceeds its cash by 76.18M USD, a debt-to-equity ratio of 0.14. Its Piotroski F-score is 9 out of 9, a strong reading of its financial health. 4 analysts cover the stock; their mean price target of 213.50 USD is 29.0% above the current price. The next earnings report is expected on 19 February 2027.